Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Kadcyla 100mg Injection
Manufacturer/Marketed By : ROCHE PRODUCTS INDIA PVT LTD
$1716.70 $1373.36
Kadcyla 100mg Injection consists of the active ingredient Ado-Trastuzumab emtansine. It is a prescription medication used to treat HER2-positive breast cancer that has spread to other parts of the body...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
ADO-TRASTUZUMAB EMTANSINE
Active Pharmaceutical Ingredient
Kadcyla 100mg Injection
1 716,70$
1 373,36$
Kadcyla 100mg Injection consists of the active ingredient Ado-Trastuzumab emtansine. It is a prescription medication used to treat HER2-positive breast cancer that has spread to other parts of the body or has not responded to other treatments. It is a combination of two drugs: trastuzumab, which is an antibody that targets HER2 receptors, and emtansine, which is a chemotherapy drug that kills cancer cells. It is indicated to treat breast cancer in the early stages as well as advanced stages, where patients develop recurrence within six months of chemotherapy treatment. This medication acts against tumours that produce more than the normal amount of a certain protein (known as HER2 protein). Patients with residual breast cancer after chemotherapy treatment and HER2-targeted therapy have a poorer prognosis than those with no residual cancer. Report to your physician immediately if you experience side effects such as allergic reactions, unusual bleeding, etc. This medication does not show any adverse effects on the kidney. In rare cases, an infusion reaction is seen. Like all other medications, it shows mild side effects like nausea, vomiting, diarrhoea, and hair loss.
Active Pharmaceutical Ingredient
Uses
• Advanced and metastatic breast cancer
• Metastatic gastric cancer
Benefits
Ado-Trastuzumab emtansine works by combining the targeting ability of trastuzumab, which binds to HER2-positive cancer cells, with the cell-killing effects of emtansine, a chemotherapy drug. Once this medication binds to the HER2-positive cancer cells, it releases emtansine, which then enters the cancer cells and destroys them. This process helps to slow down or stop the growth of cancer, reducing the size of tumors and potentially extending the patient's life.
Side Effects
Kadcyla side effects can range from anywhere between mild and serious. Here's what to know:
Most Common Side Effects
• Fatigue
• Nausea
• Constipation
• Muscle or joint pain
• Headache
• Fever
• Low platelet count
• High liver enzyme levels
• Low red blood cell count
• Loss of appetite
• Rash or itching
Common Side Effects
• Infusion reactions, including fever, chills, rash, or difficulty breathing
• Lung problems, including shortness of breath, cough, or fever
• Heart problems, including heart failure or abnormal heart rhythms
• Severe bleeding or bruising
• Nerve damage, including numbness, tingling, or weakness
• Severe allergic reactions
How To Use
Kadcyla 100mg Injection is administered by a healthcare professional in a hospital or clinic setting. The dose and frequency depend on several factors, such as the individual's age, weight, overall health, and the type and stage of the cancer being treated.
Safety Advice
• Breast Feeding: Avoid breastfeeding your baby while on the treatment with Kadcyla 100mg Injection at least seven months after the final dose.
• Alcohol: It is recommended to avoid consuming alcohol while taking Kadcyla 100mg Injection, as alcohol can increase the risk of certain side effects associated with the medication, such as stomach ulcers or gastrointestinal bleeding.
• Liver: Kadcyla 100mg Injection can affect liver function, and in rare cases, it can cause liver damage, including hepatotoxicity and liver failure. Therefore, it's important to inform your healthcare professional if you have any history of liver problems, such as hepatitis or cirrhosis, before starting treatment.
• Lungs: Kadcyla 100mg Injection safety and efficacy have not been extensively studied. So patients with pre-existing lung conditions should consult a doctor before taking it.
• Driving: Kadcyla 100mg Injection can cause unusual tiredness and dizziness. Hence, it is advised to avoid driving or handling machinery during the treatment.
• Pregnancy: Discuss with your physician before taking this Kadcyla 100mg Injection if you are pregnant or think you might be pregnant. Do not take this medicine during the pregnancy unless advised by the doctor to take as it may cause harm to the unborn baby.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.